We may still be five Years out until We Can Sequence Everyone I had the chance to attend the Precision Medicine World Conference PMWC 2023 SV in the last couple of days. Some 2,000+ individuals from across the life...read more
Latest news and features
Goodbye 2022 – Hello 2023
We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more
ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists
This month’s “Company Spotlight” provides a closer look at ONTOFORCE, the creator of a semantic search technology platform for insight generation. I spoke with Valerie Morel, CEO of ONTOFORCE, about ONTOFORCE’s platform...read more
Time Is What We Want Most – Why Wasting Any More of It?
As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more
Deepcell Aims to Create a Single Cell Morpholome Platform
This month’s “Company Spotlight” takes a closer look at Deepcell, a company that is building a platform for the identification, isolation, and classification of viable cells based on their morphological distinctions for...read more
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials
Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio LLC product offering. This new report provides insights into...read more
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A True Testimony that we Sit at The Intersection of Significant New Opportunities The significant opportunities at the intersection of biology, technology, and big data and the advancements resulting from...read more
Patient-Centric Rare Disease Genome Maps Join The Web
For far too long, rare disease patients and their guardians have had to wait “forever” for genetic information to be returned back to them. All of that is about to change: thanks to the convergence of mapping...read more
Enabling Precision Medicine: Life (Sciences) in 2030
Just 20 years ago, some expected the human genome to hold all the answers. Instead, we accumulated an almost unlimited backlog of new questions – a direct consequence of the ever-growing interest in unlocking the...read more
